Security Snapshot

AMGEN INC - Common Stock (AMGN) Institutional Ownership

CUSIP: 031162100

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

3,047

Shares (Excl. Options)

435,935,239

Price

$327.31

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
AMGN on Nasdaq
Shares outstanding
538,607,950
Price per share
$351.85
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
435,935,239
Total reported value
$142,634,971,398
% of total 13F portfolios
0.11%
Share change
+11,937,204
Value change
+$3,956,281,266
Number of holders
3,047
Price from insider filings
$351.85
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • AMGN - AMGEN INC - Common Stock is tracked under CUSIP 031162100.
  • 3047 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 3,047 to 919 between Q4 2025 and Q1 2026.
  • Reported value moved from $142,634,971,398 to $4,607,343,579.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 3047 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 031162100?
CUSIP 031162100 identifies AMGN - AMGEN INC - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of AMGEN INC - Common Stock (AMGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.6% $11,782,144,305 40,830,830 BlackRock, Inc. 31 Mar 2025

As of 31 Dec 2025, 3,047 institutional investors reported holding 435,935,239 shares of AMGEN INC - Common Stock (AMGN). This represents 81% of the company’s total 538,607,950 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AMGEN INC - Common Stock (AMGN) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 54,838,826 +1.8% 0.26% $17,949,296,138
BlackRock, Inc. 8.8% 47,396,138 +3% 0.26% $15,513,229,833
STATE STREET CORP 5.7% 30,591,403 +4.4% 0.34% $10,012,872,116
Capital World Investors 4.3% 23,097,711 +23% 1% $7,560,249,344
Capital International Investors 3.4% 18,186,270 -5.2% 0.93% $5,952,964,722
MORGAN STANLEY 2.9% 15,744,528 -1% 0.31% $5,153,342,607
GEODE CAPITAL MANAGEMENT, LLC 2.7% 14,303,294 +7.8% 0.29% $4,665,822,333
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.2% 11,811,045 -13% 0.6% $3,865,873,139
PRIMECAP MANAGEMENT CO/CA/ 1.7% 8,904,979 -8.3% 2.2% $2,914,688,677
WELLS FARGO & COMPANY/MN 1.3% 7,110,693 -0.65% 0.46% $2,327,400,741
NORGES BANK 1.2% 6,611,965 0.23% $2,164,162,264
NORTHERN TRUST CORP 1.1% 6,181,658 +0.61% 0.26% $2,023,318,481
BANK OF AMERICA CORP /DE/ 1% 5,537,361 +6.8% 0.13% $1,812,433,488
Invesco Ltd. 0.89% 4,788,460 +7.2% 0.24% $1,567,310,831
ROYAL BANK OF CANADA 0.87% 4,704,930 +3.8% 0.27% $1,539,969,000
Capital Research Global Investors 0.86% 4,648,155 -1.8% 0.28% $1,521,390,119
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.85% 4,604,019 +1.2% 0.32% $1,506,941,458
GOLDMAN SACHS GROUP INC 0.84% 4,530,258 +1.9% 0.21% $1,482,798,639
UBS Group AG 0.76% 4,104,524 -3% 0.27% $1,343,451,751
Bank of New York Mellon Corp 0.73% 3,907,016 -1.8% 0.23% $1,278,805,259
Legal & General Group Plc 0.71% 3,811,451 +2.5% 0.28% $1,247,526,029
FMR LLC 0.67% 3,592,220 +5.5% 0.06% $1,175,769,605
Amundi 0.63% 3,396,945 +41% 0.34% $1,111,854,069
Aristotle Capital Management, LLC 0.61% 3,292,564 -5.2% 2.2% $1,077,711,633
DIMENSIONAL FUND ADVISORS LP 0.6% 3,230,979 +1.6% 0.22% $1,057,561,123

Institutional Holders of AMGEN INC - Common Stock (AMGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 13,178,577 $4,607,343,579 +$272,938,422 $351.85 919
2025 Q4 435,935,239 $142,634,971,398 +$3,956,281,266 $327.31 3,047
2025 Q3 422,599,403 $119,227,071,695 -$2,429,200,844 $282.20 2,799
2025 Q2 431,017,097 $120,366,553,868 +$2,450,274,027 $279.21 2,823
2025 Q1 422,473,345 $131,531,727,085 +$1,872,368,258 $311.55 2,896
2024 Q4 417,086,000 $108,720,772,463 +$2,265,838,363 $260.64 2,826
2024 Q3 406,369,935 $130,879,980,495 -$1,604,998,262 $322.21 2,806
2024 Q2 411,362,744 $128,504,192,197 +$1,181,157,825 $312.45 2,765
2024 Q1 407,436,623 $115,716,365,294 -$702,198,897 $284.32 2,693
2023 Q4 409,933,148 $118,123,741,660 +$1,005,699,600 $288.02 2,696
2023 Q3 405,531,200 $109,011,181,196 +$229,042,644 $268.76 2,487
2023 Q2 404,699,813 $89,947,908,938 -$261,931,019 $222.02 2,372
2023 Q1 404,701,714 $97,834,318,909 -$700,557 $241.75 2,415
2022 Q4 406,077,834 $106,668,591,111 -$748,747,430 $262.64 2,484
2022 Q3 409,616,600 $92,417,131,362 -$750,583,865 $225.40 2,296
2022 Q2 412,985,046 $100,492,204,105 -$1,259,144,735 $243.30 2,339
2022 Q1 421,058,516 $101,841,258,918 -$694,689,820 $241.82 2,318
2021 Q4 423,515,516 $95,315,634,243 -$510,096,720 $224.97 2,274
2021 Q3 423,973,569 $90,218,106,763 -$1,797,171,529 $212.65 2,117
2021 Q2 432,834,503 $105,480,060,350 -$1,552,090,464 $243.75 2,177
2021 Q1 438,906,620 $109,131,112,493 +$244,673,177 $248.81 2,198
2020 Q4 438,719,413 $100,855,504,433 -$1,555,161,163 $229.92 2,206
2020 Q3 445,447,041 $113,064,795,230 -$1,516,037,134 $254.16 2,112
2020 Q2 451,020,430 $106,377,849,041 +$196,760,550 $235.86 2,080
2020 Q1 450,778,286 $91,483,976,180 -$1,036,425,103 $202.73 2,021
2019 Q4 455,053,392 $109,666,060,331 -$1,402,308,815 $241.07 2,095
2019 Q3 460,409,362 $89,117,233,590 -$453,773,888 $193.51 1,872
2019 Q2 462,969,714 $85,284,004,074 -$1,977,498,329 $184.28 1,855
2019 Q1 477,538,680 $90,681,462,101 -$2,771,862,070 $189.98 1,866
2018 Q4 492,365,399 $95,762,097,851 -$1,211,016,167 $194.67 1,876
2018 Q3 497,801,083 $103,120,954,410 -$981,718,315 $207.29 1,786
2018 Q2 502,315,893 $92,666,956,468 -$4,399,362,488 $184.59 1,750
2018 Q1 526,674,425 $89,730,269,200 -$8,140,837,372 $170.48 1,744
2017 Q4 574,140,506 $99,788,178,222 -$661,000,207 $173.90 1,729
2017 Q3 576,679,315 $107,493,711,793 +$76,885,293 $186.45 1,602
2017 Q2 576,364,305 $99,237,997,064 +$56,253,074 $172.23 1,590
2017 Q1 584,054,105 $95,822,511,549 +$8,279,146,194 $164.07 1,596
2016 Q4 582,115,959 $85,116,893,980 -$2,283,535,896 $146.21 1,535
2016 Q3 595,353,468 $99,250,036,890 -$524,318,492 $166.81 1,508
2016 Q2 598,011,068 $91,002,814,954 -$665,380,765 $152.15 1,465
2016 Q1 602,391,544 $90,302,284,138 -$510,698,255 $149.93 1,428
2015 Q4 606,076,643 $98,347,152,747 -$591,914,368 $162.33 1,451
2015 Q3 609,131,462 $84,255,457,476 +$50,194,517 $138.32 1,369
2015 Q2 608,973,000 $93,498,836,731 -$1,138,005,047 $153.52 1,359
2015 Q1 616,070,989 $98,487,680,757 -$157,310,980 $159.85 1,336
2014 Q4 617,323,710 $98,338,715,975 +$380,063,709 $159.29 1,328
2014 Q3 615,195,343 $86,408,217,315 +$1,598,394,252 $140.46 1,211
2014 Q2 603,882,660 $71,496,939,408 +$316,677,506 $118.37 1,179
2014 Q1 601,707,083 $74,167,753,469 -$844,883,264 $123.34 1,168